Gif Sur Yvette, France

Jacques De Rostolan

This inventor holds 2 USPTO granted patents. Top assignees: Procter & Gamble Pharmaceuticals, Inc., The Procter Gamble Company. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques De Rostolan. Retrieved from https://idiyas.com/inventor/jacques-de-rostolan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jacques De Rostolan

Introduction

Jacques De Rostolan, an esteemed inventor based in Gif Sur Yvette, France, has made significant contributions to the field of pharmaceuticals through his inventive prowess. With two notable patents to his name, De Rostolan's work focuses on creating compounds that hold promise for treating critical health conditions. His dedication to innovation within the sector showcases his important role in advancing medical science.

Latest Patents

De Rostolan's latest patents include the development of deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds. The first patent outlines a method for creating compounds that incorporate complex sugar structures, aiming to enhance the efficacy of treatments for various medical conditions. The specific steps in this process include adding 6-deoxy-α-L-mannopyranosyl bromide along with various solvents and bases, and heating the mixture to facilitate the reaction. The second patent further explores 14-aminosteroid compounds, emphasizing their potential pharmaceutical applications, particularly for patients suffering from congestive heart failure. These compounds, which can exist as acid salts or esters, show promising therapeutic properties.

Career Highlights

Throughout his career, Jacques De Rostolan has been associated with notable companies such as Procter & Gamble and Procter & Gamble Pharmaceuticals, Inc. His work within these organizations has been pivotal in progressing innovative health solutions. His innate ability to blend chemistry with practical application has established him as a valuable asset in the pharmaceutical industry.

Collaborations

Collaboration is key to innovation, and De Rostolan has worked alongside talented professionals such as Song Liu and David Edward Portlock. These collaboration efforts have fueled the development of his inventions, allowing for diverse perspectives and expertise to enhance the outcomes of his work.

Conclusion

Jacques De Rostolan's journey as an inventor reflects his commitment to advancing pharmaceutical science. With a focus on creating innovative compounds that can significantly impact patient treatment, his contributions are influential within the medical community. As he continues to develop new ideas and solutions, the potential for his work to improve health outcomes remains vast and inspiring.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…